Looking towards the end of current pennant into a gamma squeeze...
Options for 8/20 look like a massive gamma at 10 possible, with another big jump at 12.5 and 15. We could see a massive impulse up with intense gamma pressure from ~1.2 million shares in calls at 10, and another ~700-800k between now and 20.
All that with a massive short volume with a tiny float as is. State Street bought a ton more on the dive from $25, could be seeing institutional investors be buying up for the inevitable FDA approval into acquisition.
Comment
⋅
Freaking hidden resistance lines! I wish I could update the idea chart!
You think this one could get FDA approved? Your price target if approved?
DoctorFaustus
⋅
@e2daD, I 100% believe it will get approved, my low end target post approval is $100, while its possible it sets the record for a biotech acquisition as the drug is miles ahead better than anything else currently in development, on the market or in the works.
This is my full article for thoughts. I truly believe in CVM and #Multikine and have 50% of funds in this with the other 50% in GME. It's a short squeeze with a real biomedical breakthrough.
With that said, I absolutely believe you should do back up research because I fully acknowledge that my judgement is clouded by the possibilities of how many lives will be saved by Multikine.